Titan Pharmaceuticals Inc SC 13D and SC 13D/A reports

Location
400 Oyster Point Blvd, Suite 505, San Francisco, CA
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
8/22/2024, 01:26 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report SC 13D/A Aug 21, 2024
SC 13D/A Report SC 13D/A Apr 5, 2024
SC 13D Report SC 13D Oct 4, 2023
SC 13D Report Jul 21, 2023
SC 13D/A Report AMENDMENT NO. 5 TO THE SCHEDULE 13D Jun 23, 2023
SC 13D/A Report AMENDMENT NO. 4 TO THE SCHEDULE 13D Dec 15, 2022
SC 13D/A Report AMENDMENT NO. 3 TO THE SCHEDULE 13D Aug 17, 2022
SC 13D/A Report AMENDMENT NO. 2 TO THE SCHEDULE 13D Jul 8, 2022
SC 13D/A Report AMENDMENT NO. 1 TO THE SCHEDULE 13D Jun 9, 2022
SC 13D Report THE SCHEDULE 13D Apr 25, 2022
SC 13D/A Report SCHEDULE 13D - AMEND. 3 Jun 28, 2016
SC 13D/A Report SCHEDULE 13D - AMEND. 2 Jun 3, 2016
SC 13D/A Report TITAN PHARMACEUTICALS, INC.-AMEND. #1 Feb 12, 2016
SC 13D Report SCHEDULE 13D Dec 4, 2013